Does the media refer more to PNTG or SHC?

In the previous week, The Pennant Group had 3 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for The Pennant Group and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.15 beat The Pennant Group's score of 0.77 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CAI or PNTG?

In the previous week, The Pennant Group had 1 more articles in the media than Caris Life Sciences. MarketBeat recorded 4 mentions for The Pennant Group and 3 mentions for Caris Life Sciences. The Pennant Group's average media sentiment score of 0.77 beat Caris Life Sciences' score of 0.40 indicating that The Pennant Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral The Pennant Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PNTG or RDNT?

In the previous week, The Pennant Group and The Pennant Group both had 4 articles in the media. The Pennant Group's average media sentiment score of 0.77 beat RadNet's score of 0.31 indicating that The Pennant Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, PNTG or BLLN?

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Pennant Group $947.71M 1.11 $29.58M $0.85 35.68 Billiontoone $305.11M 15.97 $7.45M $0.55 192.59

Does the media refer more to PNTG or BLLN?

In the previous week, The Pennant Group had 2 more articles in the media than Billiontoone. MarketBeat recorded 4 mentions for The Pennant Group and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.38 beat The Pennant Group's score of 0.77 indicating that Billiontoone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer PNTG or VCYT?

In the previous week, Veracyte had 9 more articles in the media than The Pennant Group. MarketBeat recorded 13 mentions for Veracyte and 4 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.77 beat Veracyte's score of 0.40 indicating that The Pennant Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 2 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral

The Pennant Group (PNTG) Competitors

$30.33 -0.02 (-0.07%)

As of 01:05 PM Eastern

Compare

PNTG vs. SHC, CAI, RDNT, BLLN, and VCYT

Should you buy The Pennant Group stock or one of its competitors? MarketBeat compares The Pennant Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with The Pennant Group include Sotera Health (SHC), Caris Life Sciences (CAI), RadNet (RDNT), Billiontoone (BLLN), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does The Pennant Group compare to Sotera Health?

The Pennant Group (NASDAQ:PNTG) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Sotera Health has a net margin of 9.91% compared to The Pennant Group's net margin of 2.96%. Sotera Health's return on equity of 39.73% beat The Pennant Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Sotera Health	9.91%	39.73%	7.05%

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 6.9% of The Pennant Group shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.11	$29.58M	$0.85	35.68
Sotera Health	$1.16B	3.87	$77.94M	$0.41	38.52

The Pennant Group has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market.

The Pennant Group currently has a consensus price target of $39.00, suggesting a potential upside of 28.59%. Sotera Health has a consensus price target of $20.33, suggesting a potential upside of 28.73%. Given Sotera Health's higher possible upside, analysts plainly believe Sotera Health is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

In the previous week, The Pennant Group had 3 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for The Pennant Group and 1 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.15 beat The Pennant Group's score of 0.77 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sotera Health beats The Pennant Group on 12 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and The Pennant Group (NASDAQ:PNTG) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Caris Life Sciences presently has a consensus price target of $27.56, indicating a potential upside of 60.49%. The Pennant Group has a consensus price target of $39.00, indicating a potential upside of 28.59%. Given Caris Life Sciences' higher possible upside, equities research analysts plainly believe Caris Life Sciences is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88

85.9% of The Pennant Group shares are owned by institutional investors. 50.0% of Caris Life Sciences shares are owned by insiders. Comparatively, 6.9% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, The Pennant Group had 1 more articles in the media than Caris Life Sciences. MarketBeat recorded 4 mentions for The Pennant Group and 3 mentions for Caris Life Sciences. The Pennant Group's average media sentiment score of 0.77 beat Caris Life Sciences' score of 0.40 indicating that The Pennant Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
The Pennant Group	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Caris Life Sciences has a net margin of 3.75% compared to The Pennant Group's net margin of 2.96%. Caris Life Sciences' return on equity of 98.28% beat The Pennant Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
The Pennant Group	2.96%	10.07%	4.23%

The Pennant Group has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	5.98	-$68.09M	-$7.61	N/A
The Pennant Group	$947.71M	1.11	$29.58M	$0.85	35.68

Summary

The Pennant Group beats Caris Life Sciences on 9 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to RadNet?

The Pennant Group (NASDAQ:PNTG) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

The Pennant Group has higher earnings, but lower revenue than RadNet. RadNet is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.11	$29.58M	$0.85	35.68
RadNet	$2.04B	2.02	-$18.65M	-$0.18	N/A

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

The Pennant Group has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market. Comparatively, RadNet has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market.

The Pennant Group has a net margin of 2.96% compared to RadNet's net margin of -0.66%. The Pennant Group's return on equity of 10.07% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
RadNet	-0.66%	2.77%	0.97%

The Pennant Group currently has a consensus price target of $39.00, suggesting a potential upside of 28.59%. RadNet has a consensus price target of $87.43, suggesting a potential upside of 66.56%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, The Pennant Group and The Pennant Group both had 4 articles in the media. The Pennant Group's average media sentiment score of 0.77 beat RadNet's score of 0.31 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

The Pennant Group beats RadNet on 10 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to Billiontoone?

The Pennant Group (NASDAQ:PNTG) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

In the previous week, The Pennant Group had 2 more articles in the media than Billiontoone. MarketBeat recorded 4 mentions for The Pennant Group and 2 mentions for Billiontoone. Billiontoone's average media sentiment score of 1.38 beat The Pennant Group's score of 0.77 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

The Pennant Group has a net margin of 2.96% compared to Billiontoone's net margin of 0.00%. The Pennant Group's return on equity of 10.07% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Billiontoone	N/A	N/A	N/A

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.11	$29.58M	$0.85	35.68
Billiontoone	$305.11M	15.97	$7.45M	$0.55	192.59

The Pennant Group presently has a consensus target price of $39.00, suggesting a potential upside of 28.59%. Billiontoone has a consensus target price of $125.29, suggesting a potential upside of 18.28%. Given The Pennant Group's stronger consensus rating and higher probable upside, equities analysts plainly believe The Pennant Group is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

85.9% of The Pennant Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

The Pennant Group beats Billiontoone on 12 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to Veracyte?

The Pennant Group (NASDAQ:PNTG) and Veracyte (NASDAQ:VCYT) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Veracyte has a net margin of 16.25% compared to The Pennant Group's net margin of 2.96%. The Pennant Group's return on equity of 10.07% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Veracyte	16.25%	9.07%	8.38%

Veracyte has lower revenue, but higher earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.11	$29.58M	$0.85	35.68
Veracyte	$517.15M	7.54	$66.35M	$1.09	44.86

85.9% of The Pennant Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 1.4% of Veracyte shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

The Pennant Group presently has a consensus target price of $39.00, indicating a potential upside of 28.59%. Veracyte has a consensus target price of $47.57, indicating a potential downside of 2.72%. Given The Pennant Group's stronger consensus rating and higher probable upside, equities analysts clearly believe The Pennant Group is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56

The Pennant Group has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market. Comparatively, Veracyte has a beta of 1.98, meaning that its stock price is 98% more volatile than the broader market.

In the previous week, Veracyte had 9 more articles in the media than The Pennant Group. MarketBeat recorded 13 mentions for Veracyte and 4 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.77 beat Veracyte's score of 0.40 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	2 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Veracyte beats The Pennant Group on 9 of the 17 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PNTG vs. The Competition

Export

Metric	The Pennant Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.05B	$5.56B	$6.43B	$12.45B
Dividend Yield	N/A	1.59%	2.69%	5.22%
P/E Ratio	35.68	33.21	23.85	24.37
Price / Sales	1.11	25.12	522.03	117.40
Price / Cash	24.08	15.82	41.27	57.13
Price / Book	2.80	3.09	10.04	6.75
Net Income	$29.58M	$218.81M	$3.56B	$337.03M
7 Day Performance	-11.73%	-2.50%	-0.82%	0.08%
1 Month Performance	N/A	N/A	N/A	-1.66%
1 Year Performance	5.02%	10.87%	28.88%	34.01%

The Pennant Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PNTG The Pennant Group	4.6086 of 5 stars	$30.33 -0.1%	$39.00 +28.6%	+4.4%	$1.05B	$947.71M	35.68	9,700
SHC Sotera Health	3.7986 of 5 stars	$15.54 -2.6%	$20.33 +30.8%	+24.3%	$4.55B	$1.16B	37.90	3,000
CAI Caris Life Sciences	4.7743 of 5 stars	$15.38 -0.9%	$27.56 +79.2%	N/A	$4.39B	$812.03M	N/A	1,846	Analyst Downgrade
RDNT RadNet	3.6525 of 5 stars	$53.84 -0.5%	$87.43 +62.4%	-11.6%	$4.26B	$2.04B	N/A	11,264
BLLN Billiontoone	4.4565 of 5 stars	$91.02 +7.7%	$125.29 +37.6%	N/A	$3.89B	$305.11M	165.49	620	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PNTG) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Pennant Group (PNTG) Competitors

PNTG vs. SHC, CAI, RDNT, BLLN, and VCYT

How does The Pennant Group compare to Sotera Health?

Summary

How does The Pennant Group compare to Caris Life Sciences?

Summary

How does The Pennant Group compare to RadNet?

Summary

How does The Pennant Group compare to Billiontoone?

Summary

How does The Pennant Group compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

The Pennant Group (PNTG) Competitors

PNTG vs. SHC, CAI, RDNT, BLLN, and VCYT

How does The Pennant Group compare to Sotera Health?

Is PNTG or SHC more profitable?

Do insiders & institutionals believe in PNTG or SHC?

Which has better earnings & valuation, PNTG or SHC?

Which has more volatility and risk, PNTG or SHC?

Do analysts rate PNTG or SHC?

Does the media refer more to PNTG or SHC?

Summary

How does The Pennant Group compare to Caris Life Sciences?

Do analysts prefer CAI or PNTG?

Do insiders and institutionals have more ownership in CAI or PNTG?

Does the media prefer CAI or PNTG?

Is CAI or PNTG more profitable?

Which has stronger valuation and earnings, CAI or PNTG?

Summary

How does The Pennant Group compare to RadNet?

Which has preferable earnings & valuation, PNTG or RDNT?

Do insiders and institutionals hold more shares of PNTG or RDNT?

Which has more volatility and risk, PNTG or RDNT?

Is PNTG or RDNT more profitable?

Do analysts rate PNTG or RDNT?

Does the media favor PNTG or RDNT?

Summary

How does The Pennant Group compare to Billiontoone?

Does the media refer more to PNTG or BLLN?

Is PNTG or BLLN more profitable?

Which has preferable earnings & valuation, PNTG or BLLN?

Do analysts recommend PNTG or BLLN?

Do institutionals & insiders hold more shares of PNTG or BLLN?

Summary

How does The Pennant Group compare to Veracyte?

Is PNTG or VCYT more profitable?

Which has better valuation & earnings, PNTG or VCYT?

Do insiders and institutionals have more ownership in PNTG or VCYT?

Do analysts prefer PNTG or VCYT?

Which has more volatility and risk, PNTG or VCYT?

Does the media prefer PNTG or VCYT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools